Search
for
Sort by
Research 151–180 of 321
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- Dermatologic Reactions to Targeted Therapy
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- “PRIDE” Complex
- Atypical folliculitis caused by Malassezia spp. in immunosuppressed patients
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- The management and treatment of acne
- Pyodermatitis vegetans associated with multiple myeloma
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Use of Plasma-Rich in Growth Factors (PRGF) in the Treatment of Acne
- Topical retinoids: role and place in acne therapy
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- Treatment of acne with intermittent isotretinoin, cohort study
- Chemotherapy and Cutaneous Drug Reactions
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique